PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Sep-2024 Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies AccessWire
26-Sep-2024 Angle PLC Announces Half-year Report AccessWire
26-Sep-2024 Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies Evotec SE
26-Sep-2024 Unleash the Potential of Serum Untargeted Metabolomics with Creative Proteomics Creative Proteomics
26-Sep-2024 Creative Proteomics Launches Advanced Protein Purity and Homogeneity Characterization Service Creative Proteomics
26-Sep-2024 Protheragen Launches In Vitro Mitochondrial Analysis Services to Facilitate Therapeutic Research for Mitochondrial Diseases Protheragen
26-Sep-2024 Amerigo Scientific Unveils Customized Fermenters Aimed at Expanding Access to Flexible Fermentation Tanks Amerigo Scientific
26-Sep-2024 Applied Science Releases New Advanced Technologies to Improve Care for People Living With Diabetes in Rural and Under-Served Communities AccessWire
25-Sep-2024 Coalition for Patient Rights (CPR) Urges Immediate Medical Cannabis Law Reform in Nevada with Broad Support from Integrative Healthcare AccessWire
25-Sep-2024 Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model ABIVAX
25-Sep-2024 Prevail Partners and Prevail InfoWorks Enter Into Strategic Investment and Clinical Alliance With Kairos Pharma, Ltd. AccessWire
25-Sep-2024 Gruber Plastic Surgery Dispels Misconceptions on Awake Surgeries AccessWire
25-Sep-2024 Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers Lantern Pharma
25-Sep-2024 Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference AccessWire
25-Sep-2024 Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion
25-Sep-2024 New data show Almirall´s EBGLYSS® (lebrikizumab) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis Almirall
25-Sep-2024 Semaglutide improves outcomes for obese patients with common skin condition, new study shows European Academy of Dermatology and Venereology (EADV)
25-Sep-2024 Arctoris announces strategic partnership with Alphabet company, Isomorphic Labs Arctoris
25-Sep-2024 Royal Columbian Hospital Foundation’s Advancing Innovation in Medicine (AIM) division supports Steriwave ICU use with clinical trials at Royal Columbian Hospital Ondine Biomedical Inc
25-Sep-2024 Univo IRB Launches Canadian Research Ethics Board Review Services for Clinical Trials in North America Univo IRB